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We report here the purilt¢=~tion of ten|tscin, an exlracdluhtr matrix rnulecule involved in the control or morphosen¢~is, From the ¢ondhloned medium 
of th© ,¥¢nupus XTC cell line, Tenant:in was purified by i:l~nhy chromatollraphy on a ~;olumn of" the inont~lol"lal untibody mAb TnM I; the m~leeule 
eluled from this coiull~ll Ii:~it a relative mol¢cuhlr m~tss of 210 kDa ~l'ter eduction. Electrophoretie analysi~ under non.reduein~ condiiion:~ ~how~ 
Ihal the purified components are olisomerie disulfide.linked or0 ~lcxe=t which barely enter n 4~, polyacr),htmid¢ gel. Upon rotary d~adowinll these 
molecules appear to possess =~ central 81obnlar domain to whi~l~ p~lir,t or triplelS ot'arms are ~tl~tchetJ, Polyclon.'d tlntibodies h~tvc been rai~ed ~sainst 
purified Xrnopus tcna~in, They recosnise ~pccil~¢ally the ¢lntiien on We,ttern blots oi" ×TC conditioned medium and adult bru in, by immunofluores. 
¢ence, lhes. untibodi¢~ reveal I'trl~¢ umounls of tena~cin the s~retory vc~i¢les a~ well ,'t=t in the extracdtul~r mlllrix ot XTC eel is, h'= the .Ve, opux 
tadpole, th~.y',lain the devclopin8 ¢artiht~,e, the basal amina ofsk n cpidermi,,, myotendlnou!t lisaments and restricted resions of the central nervous 
~,'$te111, 
Tcnascin: Antibody; Extracellular rnatrix; Xenr~pus 
1. INTRODUCTION 
Tenascin is a component of the extracelh|lar matrix 
(ECM) whose expression during development and 
regeneration is closely associated with important mor- 
phogenetic events [1-4]. Originally described in the 
chicken as myotendinous antigen [5,6], tenascin is iden- 
tical or homologous to molecules discovered simul- 
taneously by ,3thor laboratories: cytotactin in the 
chicken [7-9] ;.nd glioma mesenchymal extracellular 
matrix protein in human [10], It appears furthermore 
that tenascin is the predominant mouse component 
recognized by the Jt antibody [11]. 
Electron microscopy studies have shown that 
tenascin has a six-armed structure with a central core 
named hexabrachion [9il 2-14]. The complete sequence 
of chicken tonE.seth [15-18] as well as part of that of 
human tenascin [19] have been determined. They show 
that tenascin contains EGF-like sequence repeats, 
fibrinogen- like sequences and type III fibronectin 
homologies. The latter can undergo alternative splicings 
giving rise to various molecular forms which have dif- 
ferent patterns of expression [18-20]. Tenascin affects 
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differently the adhesion of" various cell types [7,21-24] 
and inhibits the attachment of cells to FN substrates 
[24-26]. Using fusion proteins containing different 
regions of the molecule it has been shown that tenascin 
contains both cell binding sites and sequences with an- 
tiadhesive ffects [18] providing a possible interpreta. 
tion of its versatile behavior asit appears plausible that 
tenascin modulates cell-substrate adhesion by several 
different molecular mechanisms. 
Tenascin expression is strongly modulated where 
morphogenetic rearrangements take place both in the 
developing embryo and in differentiating tissues 
[8,22,27]. Tenascin has been implied in the develop- 
ment of muscle and myotendinous structures [5,6], car- 
tilage and bone [28], central nervous ystem [1,7,29,30], 
intestine [31], kidney [32], mammary glands [33], tooth 
[34] as well as in regenerative processes [3,35,36]. 
Tenascin is deposited in the ECM bording the neural 
crest cell migration pathways in mammal, avian and 
amphibian embryos where it might modulate the in- 
teractions of migrating cells with fibronectin 
[8,22,27,37-39]. The amphibian provides a suitable 
system for studies on early embryogenesis, metamor. 
phosis and regeneration [40-42]. Several studies have 
already appeared on tenascin distribution in amphi- 
bians [3,27,37,38]. However, all of them have made use 
of cross-species antibodies and no study has so far been 
performed using anti-amphibian tenascin antibodies. In 
this study we report purification and characterization 
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o f  tenascin: f rom the amphibian Xenopus Iaevts. We 
have used ~lle condit ion~d medium or  the Xenopus 
established cell l ine XTC as a source or t©nasctn. The 
product ion and specificity o f  anti.Xenopus tenascin an- 
tibodies are describe:d, 
2. MATERIALS  AND METHODS 
2, I, Pr¢l~mti~a of ¢o,ditiom=d mtdi# 
W¢ used the conditioned m<dta produced by four Xtnapux ¢¢1| 
lines: XTC [4)], XL [441, XLI'i? and KR [4~) provided by Dr J.C 
Smllh (National Institute for Nledi¢al Research, LondonL The cells 
were cultured at 2~'C in keibovit~ k.l$ medium (Gib~:o, France) 
diluted to 61% and supplemenled with ro¢tal calf serum to 10% Con. 
dittoned media or these tells were prepared from eonfluem tell 
tultnres, No need w~ts found or usln= serum.free media zts, in control 
¢speriments. we did not ¢let¢ct the presence of any contaminating 
tenascin i  tl~e batch of serum II~at we used, 
2,2, Amihodie~, chicken ttt)dt¢.ln 
Tlte production anti specificity or antiserum to chicken fibroblast 
tenascin and of monoclonal antibody mAB TnMI I~ave been already 
reported iS,6), Purified tenas¢In from chicken embryo fibroblasts was 
obtained as described [61. 
2.L P~trifitallot, of Xenopus tenox¢in end prepuratioa of the 
#miboaies 
Tenascin was purified by immunoarf[nity chromatography on n 
column of immobilized mAb TnMI as described [6]. The cross. 
reactivity of mAb TnMI with Xetmpus tenascin was tested by ira. 
munopmcipitatlon experiments (not shown), Coupling of mAb TnM I 
with CNBr.attivated Sepharose CL4B (Pharmacia) was performed 
according to the manufacturer's instructions, Five mi of mAb 
TnMl-eonjugated $¢pharose were mixed with 300 ml of XTC. 
conditioned medium and incubated for 18 I1 at 4"C with gentle shak, 
rag, After incubation, Sepharose beads were poured in a l0 ml syringe 
plugged with glass wool and were washed by passing l0 ml of 0,05el0 
Triton X.t00, 0,5 M NaCI, 20 mM Tris-HCI, pH 8,4, followed by 10 
ml of 0,5 M NaCI, 20 mM Tris-HCI, pH 8,4. Tenascin was ¢lutcd with 
5 ml prO, l M triethylarnine. Eiuted fractions (0.2S ml) were collected 
and analyzed by SOS.PAGE. Fractions containing tenascin were 
pooled and incubated with gelatin-Sepharose in order to eliminate ny
contaminating fibronectin which could have to-purified with 
tenascia. After sedimentation of gelatin-Sepharose, protein concen- 
tration of the su pernatant was determined by measuring OD:,o, Pool. 
ed fractions were stored at -20=C, 
Anti.Xenopus tenascin antibodies were prepared by injecting the 
purified protein i to rabbits in the presence of Freund's adjuvant, 
The primary injection was performed with 150 #g of tenascin 
emulsified with complete Freund's adjuvant, Rabbits were boosted 
twice with 75 ~g of tenascin emulsified with incomplete Freund's ad. 
juvant, They were bl d 2 weeks after the last injection and lhen every 
2 weeks during 2 months, Sera were prepared and titrated byELISA. 
lgGs were purified by ion.exchange chromatography on DEAE 
trisacryl, 
2,4, Rotary shadowing elecrtotJ microscopy 
Rotary shadowing and electron microscopy were carried out as 
described [2S]. 
2,5, Electrophoresis; Western blots 
Proteins were analyzed by SOS.PAGE according to [46], Xenopus 
adult brain proteins were solubilized according to the high pH method 
of [8], Samples were either prepared in the ~resen¢¢ of 5°70 
2.mercaptoethanol to disrupt disulfide bridges (reducing conditions) 
or without 2-mercaptoethanol (non.reducing conditions), Coomassie 
blue staining ofgels as well as electrotransfer and immunodetection 
were performed as described [47], 
L6, lmmtu)ohi~tu¢hemi~lr, v 
P~r~ffln s¢~tiont ~f metamorphlc Xenopus were Prel~red for 
'mttnlns and proces,~d as preHoudy d~seribed [41[11 NTC ~clls were 
¢~liurcd oo ribro~e~tin.¢~led izlas~ ~;ovtr.tlip~ and ~t~in~d ~s dr. 
+¢rlbed lob  
3. RESULTS AND DISCUSSION 
3,1, Isolation one/¢horacteri~.arion ofXenopus renaacin 
from XTC culture sttpernotants 
In order to find a suitable source of  soluble tenascin, 
we probed the conditioned media of four Xenopus ceil 
lines, XTC, XL, XLIT"/and KR in Western blots with 
anti-chicken tenascin antibodies, Fig. IA shows that 
only XTC cells secrete o 210 kDa polyptpt ide which 
reacts with anti.tenascin. XTC.conditioned medium 
was then incubated with mAb TnMI coupled to 
Sepharose. We choose to use this monoclonal antibody 
to isolate Xenopus tonascin since in prel iminary ex. 
perimeats we could establish its abil ity to im- 
munoprecipitat¢ the 210 kDa Xenopus component (not 
shown) and since the condit ions to elute tenascin bound 
to this antibody are welt established [6]. SDS-PAGE 
analysis of the eluted traction shows that the 210 kDa 
protein is indeed retained by the column (Fig. I18, lane 
1), Western blots o f  the eluted fractions and of purified 
chicken tenascin were reacted with anti-chicken 
tenascin antiserum. When proteins were run under 
reducing conditions (Fig, IB, lanes 2, 3), the antiserum 
recognized the 220 kDa and 190-200 kDa bands of 
chicken tenascin as well as the 210 kDa Xenopus com- 
ponent, The presence of a unique band is similar to the 
results obtained with embryos of another amphibian 
species, Pleurodeles waltl, where anti-chicken tenascin 
antiserum immunoprecipitates only one 220 kDa 
polypeptide [27]. When blots were performed after pro- 
tein electrophoresis under non-reducing conditions, the 
Xenopus component behaved very similar to chicken 
tenascin (Fig, 1C), Both proteins barely entered a 4°70 
polyacrylamide gel showing that the Xenopus compo- 
nent isolated by affinity for mAb TnMI is actually a 
disulfide-linked oligomer formed of 210 kDa polypep- 
tid s. Two distinct bands can be observed for the 
purified Xenopus protein indicating that different 
oligomeric forms are present. 
In order to ascertain that the purified Xenopus pro- 
tein is X'enopus tenascin, we have observed its structure 
by electron microscopy. Upon rotary shadowing, the 
molecules appear to be formed of pairs or triplets of  
arms attached to a central globular domain at opposite 
sites (Fig. 2), The arms of the molecule contain a thin 
region attached to the central core followed by a thicker 
part which is terminated by a globular domain as 
observed for tenascin isolated from other species 
[1,2,9,12-14], However, molecules with 3, 4 or 5 arms 
were present but we failed to see the typical six-armed 
oligomers. This might be due to some proteolytic a tivi- 
ty present during the cell culture or the purification 
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l'ig. I. Purification and characterization of Xenopus tenascin, (A} Idlntlflcation of tcnascln in the mcdlurn or XTC c~lls, ImPnunoblotzinll or condi, 
lioned media with anti.chicken tenascin antis~rmn (1/100) and pcro,',~idase.conjugaled tloat anti.rabbit IgG antibody (1/200). (I) XTC', (2) ~L; (3) 
XL 177; (4) KR (B,C) Characterization of the Xenoptht 210 kDa component, (B) Rcduclnlll conditions, (I} Coomassie blue stainin= of the eluted 
protein; (2, .1)Western blots (san'~e conditions as in A), (2) A'e~mpus 2 I0 k Da IWOtein, (3) ptirified clticken tenascin. (C) Non.redacin= condllions, 
Western b[ots (same conditions as in tA). (I) XenopuJ protein, (2) Purified chicken tcnascin. 
steps rather than indicating a difference in the 
oligomeric form of the Xenopus  molecule, 
3,2. Product ion  and  spec i f ic i ty  o f  ant i .Xenopus  
tenascin ant ibod ies  
Purified Xenopus  tenascin was injected into rabbits 
to produce polyclonal antibodies, The specificity of 
these antibodies was determined by Western blotting, 
When purified ant i .Xenopus  tenascin igGs were in- 
cubated with blots of XTC-conditioned medium they 
reacted only with t e 210 kDa component (Fig, 3A). 
Ant i .Xenopus  tenascin antibodies were also tested on 
adult tissue extracts, We chose adult brain since cross- 
reactivity of anti-chicken tenascin antiserum with 
P leurode les  tenascin had been studied on this tissue 
[27]. Fig, 3B shows that the antibody reveals three 
bands of 200 kDa, 210 kDa and 300 kDa. The observa- 
tion that additional forms of tenascin polypeptides are 
expressed in the adult brain is not surprising since 190 
kDa, 200 kDa, 220 kDa and 240 kDa compounds were 
,,; .. rT'r : i  ~,; ,"  ,~ ,!.,,,, " . .~ ,  ),. ~; ~.:;.,..: ' , . :~ :  
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Fig. 2i Rotary shadowed electron micrograph of the pur i f iedXenopus  
protei n, (A) Oligomeric form with five arms. (B) Trimeric form, 
Magnification: 200 000 x ,  
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found to react with anti-chicken tenascin polypeptides 
in the adult P leurode les  brain, On the other hand, high 
molecular mass forms of tenascin polypeptides are 
present in the human (320 kDa) and the mouse (260 
kDa) [2,501. 
Finally, we have determined the distribution of 
tenascin by immunohistochemistry both on cultured 
XTC cell lines and on developing Xenopus  tissues. 
In XTC cell lines, tenascm appeared to be 
predominantly localized in secretory vesicles (Fig, 4A) 
and could be found uniformly deposited in the ECM in 
more advanced cultures, This subcellular distribution is
in line with the presence of tenascin in the medium con. 
ditioned by this cell line, During further development 
kDa ...... aoo-- 
--116 
_97  
-66  
A.  B 
- Fig, 3, Specificity of ant i .Xenopus  tenascin IgG, Imrnunoblott ing 
with ant i .Xenopus  tena~cin IgG (20 /~g/ml) and peroxidase. 
conjugated goat anti-rabbit lgG antibody (1/200),  (A) XTC. 
condi!ioned medium, (B)Adult  brain, 
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Fig, 4. Immtmohistodten~iea110¢=tli~,ation ofXenapus tena~¢in, (A) Cultured XTC cells ~taine¢ byanti.Xeaapus ten~l~:~:in antibodies (I/200), The 
~(ain a~ Is very strong in secretory, ve~i¢le~ and in the Gol~i apparatus, (B) Se~:tion through the developintt linch 0f a sta,~e $5 Xeaol.~u$ I~ldpol¢, 
Strong tenascin immtmorcacti~ity is I~resem i. the basal lamina of the skin and in all Ihe sites of c'.¢rlil.'tge condensation, (C) Section throu~,h the
junet=on of two muscular masses in tile verttral aspect of a stage 53 ,,~llO[.)lt$, Tenascin immunoreaetivily is restrictetl to ttle perimysium. (D) Section 
through the t¢¢lal area of a ~;la~,e 5~ .¥¢oot~tts eentr.al nervou~ systen',. T a,~ein in~munoreaetb,'it>' i5 restricted to a s=nall area 5urro~mding the epen. 
dym~ m, mu.~cle: , ependyme. Ma.,.,nifieation: A, 500 x ; IL 50 x ; C, D 200 x 
the major  sites of  tenascin expresston corresponded 
with those found in other species such as e,g, the 
developing carti lage (Fig. 4B), the basal lamina (Fig. 
4B), connective tissues such as the myotend inous  
l igatnents,  the per imys ium (Fig. 4C) and the per iosteum 
and some restricted areas of the central nervous system 
(Fig. 4D), It must be noted that  when sequential  sec- 
t ions were stained with anti-Xenopus tenascin an-  
t ibodies and with ant i -chicken tenascin ant ibodies,  the 
latter could not reveal the presence of the molecule in 
some regions of the nervous ystem thus indicat ing the 
presence of addit ional  variants of the molecule in this 
t issue which are not  recognized by ant i -chick zenascin 
ant ibodies,  
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